← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Irenix Medical, Inc.
Palo Alto, CA
$5,300,439
Total funding
2
Grants
Funding over time
peak $1.2M · FY2017–22$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,300,439 · 2
By mechanism
R44$5,300,439 · 2
Investigators at Irenix Medical, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy$897,021
R44 · FY2021 · EY
A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia$859,036
R44 · FY2019 · EY
Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy$847,954
R44 · FY2020 · EY
Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy$793,154
R44 · FY2022 · EY
A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia$613,295
R44 · FY2018 · EY
A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia$581,104
R44 · FY2017 · EY
A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia$247,170
R44 · FY2020 · EY
Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy$223,095
R44 · FY2022 · EY
A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia$149,800
R44 · FY2018 · EY
A Novel Device for Ultra-Rapid Non-Pharmacologic Ocular Anesthesia$88,810
R44 · FY2020 · EY